Skip to content

A Randomized Controlled Trial on the Effects of Different Urinary Catheter Balloon Placement Sites on Recovery Following Transurethral Resection of the Prostate

A Randomized Controlled Trial on the Effects of Different Urinary Catheter Balloon Placement Sites on Recovery Following Transurethral Resection of the Prostate

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600123539
Enrollment
Unknown
Registered
2026-04-27
Start date
2026-05-01
Completion date
Unknown
Last updated
2026-05-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Benign prostatic hyperplasia

Interventions

experimental group:Inject 30–40 mL of saline into the balloon (based on the surgeon’s measurement of the depth of the prostatic fossa, ensuring that the balloon is completely situated within the fossa
stop when resistance is felt, indicating that the balloon is secured between the bladder neck and the prostatic fossa (no traction is required for fixation).
control group:Inject 20–30 mL of saline into the balloon. Pull the catheter outward to position the balloon so that it rests against the bladder neck (no need to secure it in place).

Sponsors

The Second Hospital of Lanzhou University
Lead Sponsor

Eligibility

Sex/Gender
Male
Age
18 Years to 100 Years

Inclusion criteria

Inclusion criteria: 1. Male patients aged 18 years or older; 2. Patients with a pathological diagnosis of benign prostatic hyperplasia who meet the criteria for TURP surgery; 3. Patients undergoing prostate surgery for the first time; 4. Patients with complete preoperative data, including urine flow rate and prostate ultrasound results; 5. Patients with normal urinary control prior to surgery and no history of urinary incontinence.

Exclusion criteria

Exclusion criteria: 1. Prostate cancer confirmed by digital rectal examination or needle biopsy; 2. Neurogenic bladder, urethral stricture, or a history of pelvic radiation or chemotherapy; 3. Concurrent bladder stones or bladder tumors requiring simultaneous surgery; 4. Patients with long-term indwelling urinary catheters prior to surgery; 5. Patients with severe cardiac, pulmonary, or neurological conditions who cannot tolerate surgery; 6. Patients on long-term anticoagulant therapy who cannot discontinue the medication prior to surgery; 7. Any other condition deemed by the investigator to make the patient unsuitable for participation in this trial.

Design outcomes

Primary

MeasureTime frame
Incidence of bladder spasms;Duration of gross hematuria;

Secondary

MeasureTime frame
Early postoperative urinary continence rate;Amount of postoperative irrigation solution;Time of catheter removal;Pain Score;Complications;

Countries

China

Contacts

Public ContactShang Panfeng

The Second Hospital of Lanzhou University

shangpf@lzu.edu.cn+86 931 894 2469

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: May 7, 2026